Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

Autor: W. J. Koemans, R. T. van der Kaaij, H. Boot, T. Buffart, A. A. F. A. Veenhof, K. J. Hartemink, C. Grootscholten, P. Snaebjornsson, V. P. Retel, H. van Tinteren, S. Vanhoutvin, V. van der Noort, A. Houwink, C. Hahn, A. D. R. Huitema, M. Lahaye, M. Los, P. van den Barselaar, O. Imhof, A. Aalbers, G. M. van Dam, B. van Etten, B. P. L. Wijnhoven, M. D. P. Luyer, D. Boerma, J. W. van Sandick

Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)

Abstract Background At present, palliative systemic chemotherapy is the standard treatment in the Netherlands for gastric cancer patients with peritoneal dissemination. In contrast to lymphatic and haematogenous dissemination, peritoneal disseminatio

Externí odkaz: https://doaj.org/article/917d7bd8f3964810bccea2a516335683

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

Autor: Liudmila L. Kodach, Emma C. E. Wassenaar, Petur Snaebjornsson, Henk Boot, Karolina Sikorska, Djamila Boerma, Johanna W. van Sandick, W J Koemans, Maartje Los, Cecile Grootscholten, Koen J. Hartemink, A. A. F. A. Veenhof, Rosa T. van der Kaaij

Publikováno v: Journal of Surgical Oncology. 123:904-910

Introduction The PERISCOPE I (Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyPErthermic intraperitoneal chemotherapy) study was conducted to investigate the safety and feasibility of hyperthermic int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4620996a6977f281a9dd4a8e9b192e5f
https://doi.org/10.1002/jso.26366

Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results

Autor: Emma C. E. Wassenaar, J.H.M. Schellens, D. Boerma, Henk Boot, Cecile Grootscholten, Koen J. Hartemink, Arend G. J. Aalbers, B. van Ramshorst, W J Koemans, J.W. van Sandick, A. A. F. A. Veenhof, R T van der Kaaij, Alwin D. R. Huitema, Karolina Sikorska, Maartje Los

Publikováno v: British Journal of Surgery. 107:1520-1528

Background The role of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer is unknown. This non-randomized dose-finding phase I–II study was designed to assess the safety and feasibility of HIPEC,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::662988ecb18f25baf752f8de45be0cfb
https://doi.org/10.1002/bjs.11588

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies

Autor: Henk M.W. Verheul, Nicole C.T. van Grieken, Rosa T. van der Kaaij, Adam J. Bass, Jurriën Stiekema, Victor L. J. L. Thijssen, Leonie K. de Klerk, Donald L. van der Peet, Aaron R. Thorner, Roy L. J. van Wanrooij, Manon van Engeland, Sarah Derks, Arantza Farina Sarasqueta, Johanna W. van Sandick, Maarten A. J. M. Jacobs, Ruben S. A. Goedegebuure, Annemieke Cats

Publikováno v: Molecular Oncology, 15, 901-914
Molecular oncology, 15(4), 901-914. Elsevier
de Klerk, L K, Goedegebuure, R S A, van Grieken, N C T, van Sandick, J W, Cats, A, Stiekema, J, van der Kaaij, R T, Farina Sarasqueta, A, van Engeland, M, Jacobs, M A J M, van Wanrooij, R L J, van der Peet, D L, Thorner, A R, Verheul, H M W, Thijssen, V L J L, Bass, A J & Derks, S 2021, ' Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies ', Molecular oncology, vol. 15, no. 4, pp. 901-914 . https://doi.org/10.1002/1878-0261.12907
Molecular Oncology
Molecular Oncology, 15, 4, pp. 901-914
Molecular Oncology, Vol 15, Iss 4, Pp 901-914 (2021)

Identification of molecular predictive markers of response to neoadjuvant chemoradiation could aid clinical decision‐making in patients with localized oesophageal cancer. Therefore, we subjected pretreatment biopsies of 75 adenocarcinoma (OAC) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb63e49f4f3e9c7269a4fea9d4bf26fc
http://hdl.handle.net/2066/235461

721: IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE

Autor: Remi Mahmoud, Johannes P. Schultheiss, Jonas M. Louwers, Michiel T. van der Kaaij, Boris P. van Hellemondt, Nofel Mahmmod, Petra G. van Boeckel, Bindia Jharap, Herma H. Fidder, Bas Oldenburg

Publikováno v: Gastroenterology. 162:S-184

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b23c436d5a0c271b8faaba42bb56b736
https://doi.org/10.1016/s0016-5085(22)60440-2